Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2012Open Access

The managed hypertensive: the costs of blood pressure control in a Nigerian town

View Full Paper
Ask AI
Bookmark
Share

Population

250 rural patients with primary hypertension attending a regional hospital in Southwest Nigeria, mean age…

Design

Cross-sectional

Follow-up

median 12 months (range 1-91 months) of treatment

Authors

OIOlayinka Stephen IlesanmiUniversity College Hospital, IbadanOIOlusimbo K. IgeUniversity of IbadanAAAkindele O. AdebiyiUniversity College Hospital, Ibadan

Discussion

Loading...

Member takes

Implication

High out-of-pocket costs and low control in rural Nigeria may limit adherence; leaves open whether cost-effective regimens improve outcomes prospectively.

Structured PICO

P
Population
250 rural patients with primary hypertension attending a regional hospital in Southwest Nigeria (Igbo-Ora, Oyo State), mean age 61±11.2 years, 59.2% female. 82.4% had Stage 2 hypertension at diagnosis.
I
Intervention
Antihypertensive therapy (monotherapy or combination, predominantly diuretics and alpha-methyldopa)
O
Outcome
Achievement rates of target blood pressure (BP < 140/90 mmHg or < 130/80 mm Hg for diabetics) and cost-effectiveness ratio (CER)surrogate

In rural Nigeria, the financial burden of hypertension treatment is substantial, with over half of patients spending at least 10% of their income, underscoring the need for affordable, cost-effective regimens.

Limitations

  • Cost of health care is probably underestimated as laboratory tests and hospital admissions were not included
  • Influence of patients' compliance and persistence with treatment were not considered in cost-effectiveness
  • Small number of patients on other combinations precluded them from analysis

Cite This Study

Ilesanmi et al. (2012) studied this question.

synapsesocial.com/papers/6a81cf6c28bb6950eb6103c4https://doi.org/10.11604/pamj.2012.12.96.1209
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Health Outcomes Associated With Antihypertensive Therapies Used as First-Line Agents A Systematic Review and Meta-analysis1997 · 878 citations
  2. 2Discussion1997 · 307 citations
  3. 3Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis2005 · 1,000 citations
  4. 4Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes2001 · 6,047 citations
  5. 5Diagnosis and Management of the Metabolic Syndrome2005 · 11,942 citations